Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke) header
Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke) profile picture

Professor, UC San Diego Stroke Center. Stroke researcher. @UCSDNeuro @UCSDHealth #strokepractitioner #translationalstrokeresearch #antiplatelets

San Diego, CA
Joined February 2019
Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)Photo by Dawn Meyer PhD,FNP-C,FAHA (@UCSDStroke)
Congratulations Pooja Khatri on receiving the Stroke Council Award and highlighting how we have broken down silos to improve the lives of stroke patients 🧠 #ISC2026 @StrokeAHA_ASA
1
7
125
Dawn Meyer PhD,FNP-C,FAHA retweeted
FASTEST presented at #ISC26 showed that treatment with rfFVIIa within 2 hours, even in the MSU, resulted in no difference between groups. Reduction of hematoma expansion was seen however. Subgroups treated within 90 minutes or with a spot sign did show significant difference!
2
4
14
759
Dawn Meyer PhD,FNP-C,FAHA retweeted
Medical management insights following CREST-2 from primary prevention pioneer Dr. Cheryl Bushnell - including suggestion of future updates for 2024 prevention guidelines #ISC2026 @StrokeAHA_ASA
2
15
622
Dawn Meyer PhD,FNP-C,FAHA retweeted
What's New in IVT? Relative and Absolute Contraindications #ISC26 @StrokeAHA_ASA
2
47
1
116
7,045
Dawn Meyer PhD,FNP-C,FAHA retweeted
Replying to @StrokeAHA_ASA
@StrokeAHA_ASA #ISC26 What fun moderating The Mentorship Playbook by the Stroke Career Development Committee with @GhadaMohamedMD and Oluchi, under the leadership of Dr Romero and Dr Digs. Fantastic insights & advice on effective mentorship relationships by a star studded panel
4
13
996
Dawn Meyer PhD,FNP-C,FAHA retweeted
Great talk on GLP-1 targeted therapies for stroke, cognition, & brain health. Takeaway is GLP-1s are beneficial in pts w/ prior stroke, T2DM, HTN with ⬇️ total stroke rate (16% RRR and NNT=200). GLP-1s showed no difference in preventing cognitive impairment. #ISC26 @StrokeAHA_ASA
3
6
839
Dawn Meyer PhD,FNP-C,FAHA retweeted
Data has spoken. Loudly. Watchful waiting isn’t a treatment. #EMBOLISE2 non-surgical cohort at #ISC26 shows ~2x reduction in the composite endpoint of surgical rescue, clinical deterioration, or poor outcome. NNT = 9. #MMA embolization with #Onyx > observation. “Let’s just observe” is a choice, not neutrality. Take a side with our patients. #ISC26 @medtronic #SVIN26 @svinsociety @AHAScience
2
13
61
3,152
Congratulations Dr Kazunori Toyoda on receiving the Ralph Sacco Outstanding Stroke Mentor award and your incredible contributions to generations of stroke researchers & clinicians #ISC2026 @StrokeAHA_ASA
2
5
738
Excellent discussion on the intersection of stroke & migraine with partners at @ahsheadache. #ISC2026 @StrokeAHA_ASA
4
229
No benefit with addition of TNK to EVT in basilar artery occlusion in the ATTENTION LATE trial. Sharing results of "negative" trials is critical to understanding and building on knowledge gained! #ISC2026 #negativeclinicaltrial #attentionlate @StrokeAHA_ASA
12
28
1,586
Dawn Meyer PhD,FNP-C,FAHA retweeted
Another push towards extended window TNK with results of OPTION trial showing improved excellent functional outcomes at 90d with 2.8% risk of sICH within 36h. #ISC2026 @StrokeAHA_ASA
1
3
27
1,788
Dawn Meyer PhD,FNP-C,FAHA retweeted
Choice 2: thrombectomy vs thrombectomy +IA alteplase 👉🏻favors thrombectomy + alteplase (NNT 7) 👉🏻No diff in sICH 👉🏻Difference in death likely reflects low event rate in control group #ISC26 @StrokeAHA_ASA
7
28
1,175
Dawn Meyer PhD,FNP-C,FAHA retweeted
Happening NOW at #ISC26. Elena presenting novel and methodologically rigorous data supporting anticoagulation benefit in certain ESUS patients based on phenotypic clusters.
1
9
44
2,719
Head to Room R06-R09 2/4 5pm-6pm to learn about AR & VR in stroke care🧠 @BrettCMeyerMD #ISC2026 #americanstrokeassociation
1
55
Dawn Meyer PhD,FNP-C,FAHA retweeted
Dr. Angel Chamorro presents data from CHOICE-2 trial showing IA alteplase following EVT improved functional outcomes (mRS 0-1) and patient QOL measures as well as improved reperfusion on CTP at #ISC26 @StrokeAHA_ASA
7
17
1,692
Dawn Meyer PhD,FNP-C,FAHA retweeted
Opening welcome remarks from AHA CEO Nancy Brown at #ISC26! Sharing the new 2025 guidelines for early stroke management in both adult and pediatric patient populations
2
12
981
Cracking the ICAD code by @DrRamiMorsi from @UChicago Neurology 🧠
1
2
6
427
Dawn Meyer PhD,FNP-C,FAHA retweeted
STAT 2.0 Abstract Poster! Swing by Poster Hall B to learn more. #ISC26
2
1
143
Dawn Meyer PhD,FNP-C,FAHA retweeted
We spent a decade perfecting recanalization. CHOICE-2 reminds us outcomes don’t end at TICI 2b. EVT alone: “We’re done here.” EVT + IA tPA: “Let’s actually finish the job.” mRS 0–1: 57.5% vs 42.9% Absolute benefit 15%. p = 0.002 Microvascular no-reflow is real. CHOICE-2 just made it hard to ignore.
2
65
2
165
10,094
Dawn Meyer PhD,FNP-C,FAHA retweeted
FASTEST trail presented at @StrokeAHA_ASA #ISC26 Key takeaway: Radiological improvement but no clinical benefit
4
14
961